Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 50,583 | 47,680 | 50,832 | 45,849 | 52,609 |
| Cost of Goods | 20,831 | 19,386 | 14,989 | 12,964 | 20,361 |
| Gross Profit | 29,752 | 28,294 | 35,843 | 32,885 | 32,248 |
| Operating Expenses | 45,685 | 70,746 | 71,511 | 76,742 | 85,277 |
| Operating Income | -15,102 | -42,066 | -34,679 | -42,893 | -52,668 |
| Interest Expense | 7,462 | 12,443 | 22,461 | 13,022 | 9,318 |
| Other Income | 14,939 | 99 | -13,399 | 132 | -4,260 |
| Pre-tax Income | -7,625 | -54,410 | -70,539 | -55,783 | -66,246 |
| Income Tax | 245 | 0 | N/A | N/A | N/A |
| Net Income Continuous | -7,870 | -54,410 | -70,539 | -55,783 | -66,246 |
| Net Income | $-7,870 | $-54,410 | $-70,539 | $-55,783 | $-66,246 |
| EPS Basic Total Ops | -0.13 | -1.12 | -1.85 | -1.66 | -2.61 |
| EPS Basic Continuous Ops | -0.13 | -1.12 | -1.85 | -1.66 | -2.61 |
| EPS Diluted Total Ops | -0.13 | -1.12 | -1.85 | -1.66 | -2.61 |
| EPS Diluted Continuous Ops | -0.13 | -1.12 | -1.85 | -1.66 | -2.61 |
| EPS Diluted Before Non-Recurring Items | -0.13 | -1.12 | -1.49 | -1.66 | -2.42 |
| EBITDA(a) | $-11,785 | $-39,464 | $-27,984 | $-36,863 | $-47,834 |